This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease.
Yuji Oba, MD
Advertisement
Articles by Yuji Oba, MD
Continuous home oxygen therapy for chronic obstructive pulmonary disease seems more cost-effective than other health technologies covered by Medicare, while nocturnal oxygen therapy is not.
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease
Published: February 14th 2009 | Updated:
- Cost-Effectiveness of Salmeterol, Fluticasone, and Combination Therapy for COPD
Published: April 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Boosting RSV Vaccination in Older Adults Could Save Thousands
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5
